Entropion Treatment Market Analysis

  • Report ID: 3777
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Entropion Treatment Market Analysis

Treatment (Artificial Tears, Skin Tape, Anti-inflammatory Drugs, Surgery)

The global entropion treatment market is segmented and analyzed for demand and supply by treatment into artificial tears, skin tape, anti-inflammatory drugs, surgery, and others. Out of the five types of treatment of entropy, the surgery segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the rising success of the surgery for treating entropion. There are many types of surgery that can be opted for entropion treatment, including lateral tarsal strip, rotational or everting sutures, horizontal lid tightening, modified suture canthoplasty, lower lid retractor reinsertion, and others. After an average follow-up of 13 months, a small case series of 15 patients who received solely tarsal strip treatment demonstrated no recurrence of entropion.

End-user (Specialty Clinics, Hospital)

The global entropion treatment market is also segmented and analyzed for demand and supply by end-user into specialty clinics, hospital, and others. Amongst these three segments, the specialty clinics segment is expected to garner a significant share. Entropion patients frequently struggle to blink, which can cause irritability, infection, and fatigue of the eyes. An ophthalmologist should be contacted right away if a sudden and noticeable lid droop develops. Patients suffering from entropion requires various treatment, including non-invasive and surgical and it should be conducted in specialty clinics under expert guidance with the ophthalmic diagnostic equipment. In 2022, the United States have nearly 1000 eye surgery clinics. Moreover, there are around 1300 eye specialty clinics in India.

Our in-depth analysis of the global market includes the following segments:

             By Type

  • Congenital
  • Paralytic
  • Others

          By Treatment

  • Artificial Tears
  • Skin Tape
  • Anti-inflammatory Drugs
  • Surgery
  • Others

           By End User

  • Specialty Clinics
  • Hospital
  • Others
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3777
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of entropion treatment is assessed at USD 507.6 million.

The entropion treatment market size was over USD 456.57 million in 2024 and is projected to reach USD 1.07 billion by 2037, witnessing around 6.8% CAGR during the forecast period i.e., between 2025-2037. Increasing geriatric population, rising success of the entropion treatment, the growing popularity of contact lenses, and increasing cases of dry eye syndrome will drive the market growth.

North America industry is anticipated to hold largest revenue share by 2037, due to rising cases of entropion in older adults, and higher number of people suffering with dry eye issues.

The major players in the market are Eli Lilly and Company, Bausch & Lomb Incorporated, Sun Pharmaceutical Industries Ltd., Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc., and Alembic Limited
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample